Comparison of hair follicle histology between horses with pituitary pars intermedia dysfunction and excessive hair growth and normal aged horses

Vet Dermatol. 2013 Feb;24(1):212-7.e46-7. doi: 10.1111/j.1365-3164.2012.01080.x.

Abstract

Background: Pituitary pars intermedia dysfunction (PPID) in older equids is commonly recognized by a long hair coat that fails to shed.

Objective: The aim of this study was to compare hair follicle stages in PPID-affected horses with excessively long hair coats with the stages of normal aged horses (controls) and to compare hair follicle stages in PPID-affected horses after 6 months of treatment with pergolide mesylate with those of control horses.

Animals: Eight PPID-affected horses and four normal, age-matched, control horses.

Methods: Skin biopsies were collected from the neck and rump of PPID-affected and control horses. A diagnosis of PPID was established based on hair coat changes and supportive overnight dexamethasone suppression test results. Skin biopsies were repeated after 6 months of treatment with pergolide. The number of hair follicles in anagen (A) or telogen (T) was counted for each skin biopsy using transverse sections.

Results: Pretreatment biopsies had a greater percentage of A follicles (neck 96%, rump 95%) and a lower percentage of T follicles (neck 4%, rump 5%) in PPID-affected horses than in control horses (A, neck 15%, rump 25%; and T, neck 85%, rump 75%). After treatment with pergolide, all PPID-affected horses had improved shedding, and the percentages of A follicles (neck 69%, rump 70%) and T follicles (neck 31%, rump 30%) were not different from untreated control horses (A, neck 68%, rump 82%; and T, neck 32%, rump 18%).

Conclusions: These findings document that excessive hair growth (hypertrichosis) in PPID-affected horses is due to persistence of hair follicles in A. Furthermore, treatment with pergolide improved shedding and reduced the percentage of A follicles in PPID-affected horses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging
  • Animals
  • Dopamine Agonists / therapeutic use
  • Female
  • Hair / growth & development*
  • Hair Follicle / pathology*
  • Horse Diseases / metabolism*
  • Horses
  • Male
  • Pergolide / therapeutic use
  • Pituitary Diseases / drug therapy
  • Pituitary Diseases / pathology
  • Pituitary Diseases / veterinary*
  • Pituitary Gland, Intermediate*

Substances

  • Dopamine Agonists
  • Pergolide